The overarching material developed and investigated comprises AngIV-based compounds, designed to overcome the limitations of native peptides like AngIV, which suffer from poor metabolic stability and inability to cross the BBB due to their size and hydrophilicity
BPC-157 is a localized repair peptide that acts at the injection site to accelerate tendon, ligament, gut, and joint healing through direct fibroblast activation and angiogenesis
These formulations allow for direct application to the skin, where GHK-Cu can work its magic on a cellular level
This absolute precision ensures the complete isolation of the active peptides from residual synthesis solvents
It can be safely combined with phototherapy, systemic agents, or biologics, particularly in patients with inadequate responses to monotherapy